Bicarbonate

Bicarbonate

SCHEMBL284692

O=C(O)O.O=C(O)O.[CaH2].[NaH]

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.71
CA2 P00918 1/20 0.71
CA9 Q16790 1/20 0.71
FFAR3 O14843 2/20 0.40
ACHE P22303 1/20 0.40
LCK P06239 1/20 0.40
FYN P06241 1/20 0.40
TSHR P16473 5/20 0.33
LDHA P00338 2/20 0.33
EGLN1 Q9GZT9 2/20 0.33
LMNA P02545 2/20 0.33
LDHB P07195 1/20 0.33
SRR Q9GZT4 1/20 0.33
TP53 P04637 1/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
SUCNR1 Q9BXA5 1/20 0.33
EGLN3 Q9H6Z9 1/20 0.33
GLRA1 P23415 1/20 0.31
SLC6A9 P48067 1/20 0.31
OR51E2 Q9H255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL14742787 1.00 CA1 (0.71) CA1CA2CA9FFAR3ACHE
Bicarbonate SCHEMBL28200262 1.00
Bicarbonate SCHEMBL28275631 1.00
Bicarbonate SCHEMBL787477 1.00
Bicarbonate SCHEMBL14562616 0.94
Bicarbonate SCHEMBL28490163 0.94
Bicarbonate SCHEMBL27869306 0.94
Bicarbonate SCHEMBL3336735 0.94
Bicarbonate SCHEMBL14578980 0.94
Bicarbonate SCHEMBL28232617 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4013739-B1 NEW TELESCOPING SYNTHESES OF 2-METHOXYMETHYL-P-PHENYLENEDIAMINE WELLA GERMANY GMBH (DE) 2024-10-02 EP claimed
US-20220298101-A1 NEW TELESCOPING SYNTHESES OF 2-METHOXYMETHYL-P-PHENYLENEDIAMINE WELLA GERMANY GMBH (DE) 2022-09-22 US claimed
EP-4013739-A1 NEW TELESCOPING SYNTHESES OF 2-METHOXYMETHYL-P-PHENYLENEDIAMINE Wella Germany GmbH (DE) 2022-06-22 EP claimed
WO-2021028506-A1 NEW TELESCOPING SYNTHESES OF 2-METHOXYMETHYL-P-PHENYLENEDIAMINE COTY INC. (US) 2021-02-18 WO claimed
CN-109746999-A A kind of wood fire retardant 丹阳市博元安全生产服务有限公司 2019-05-14 CN claimed
CN-109731450-A A kind of two-part flue gas aftertreatment technology 北京利德衡环保工程有限公司 2019-05-10 CN claimed
CN-104924390-A Wood fire retardant ZHANG PING 2015-09-23 CN claimed
CN-104478267-A Calcium carbonate and sodium carbonate complexing agent and preparation method thereof YIXING TIANLI CHEMICAL NANO TECHNOLOGY CO LTD 2015-04-01 CN claimed
WO-2024258616-A2 VAPOR PERMEABLE, WATER RESISTIVE, AND FIRE RESISTIVE ARTICLES HEXION INC. (US) 2024-12-19 WO disclosed
US-20240417971-A1 VAPOR PERMEABLE, WATER RESISTIVE, AND FIRE RESISTIVE ARTICLES HEXION INC. 2024-12-19 US disclosed
WO-2024258614-A2 POLE CAPS AND POLE PROTECTION SYSTEMS HEXION INC. (US) 2024-12-19 WO disclosed
US-20240417993-A1 POLE CAPS AND POLE PROTECTION SYSTEMS HEXION INC. 2024-12-19 US disclosed
WO-2023230011-A1 FIRE-RESISTANT COMPOSITIONS HEXION INC. (US) 2023-11-30 WO disclosed
US-20230374319-A1 FIRE-RESISTANT COMPOSITIONS HEXION INC. 2023-11-23 US disclosed
CN-1784223-A Use of phenoxyacetic acid derivatives for treating hyperactive bladder KISSEI PHARMACEUTICAL (JP) 2006-06-07 CN disclosed
CN-1658767-A Compositions for modulating physiological responses or inducing immune responses PEROS SYSTEMES TECHNOLOGIES IN (CA) 2005-08-24 CN disclosed
CN-1406112-A Composition for intestinal delivery AQUA SOLUTION INC (CA) 2003-03-26 CN disclosed
US-6086998-A Non-inflammable fiber product PROTEKUM UMWELTINSTITUT GMBH ORANIENBURG (DE) 2000-07-11 US disclosed
US-4440779-A Tricyclic derivatives of substituted pyrrole acids as analgesic and anti-inflammatory agents MERCK & CO., INC. (US) 1984-04-03 US disclosed
EP-0068460-A1 Tricyclic derivatives of substituted pyrrole acids as analgesic and anti-inflammatory agents MERCK & CO. INC. (US) 1983-01-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220298101-A1 NEW TELESCOPING SYNTHESES OF 2-METHOXYMETHYL-P-PHENYLENEDIAMINE PNMT, TYR, DDT CA1 4858/4885CA2 4270/4885CA9 3360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.